Summary
In vitro, Cortisol and aldosterone have a similar affinity to the mineralocorticoid
receptor. The 11β-hydroxysteroid dehydrogenase catalyzes the interconversion of Cortisol
to its inactive 11-oxo-metabolite cortisone. This interconversion is responsible for
the in vivo specificity of the mineralocorticoid receptor. A defect of this enzyme
leads to a pseudohyperaldosteronism with hypertension and hypokalemia, the so-called
apparent mineralocorticoid excess syndrome. Glycyrrhetinic acid, a compound of licorice,
also leads to pseudohyperaldosteronism by an inhibition of the 11β-hydroxysteroid
dehydrogenase.
We studied the pharmacokinetics of glycyrrhetinic acid and its effect on the 11β-hydroxysteroid
dehydrogenase. Ten healthy students, aged 24 to 38 years, were included in the study.
On the first day 500 mg glycyrrhetinic acid were given orally at 08.00 h. Blood and
urine samples were taken prior to and 2, 4, 7, 10 and 24 hours after ingestion of
glycyrrhetinic acid. We measured the serum level of Cortisol, cortisone and glycyrrhetinic
acid and the urinary excretion rates of Cortisol, cortisone and their 20-dihydrometabolites.
For determination of glycyrrhetinic acid and steroid levels we used a fully automated
liquid chromatographic analyzer which allows the highly specific and simultaneous
determination of steroid profiles even in the matrix of urine. Ratios of the 11-hydroxy-
and 11-oxo-metabolites were calculated and correlated to the serum level of glycyrrhetinic
acid. We found a significant correlation of the steroid-ratios to the serum levels
of glycyrrhetinic acid. Coefficients of correlation were 0.9873, 0.7812, 0.7396 and
0.5844 between the serum level of glycyrrhetinic acid and the cortisol/cortisone-ratio
in serum (p < 0.0001), the cortisol/cortisone-ratio in urine (p = 0.0279), the 20α-dihydrocortisol/20oc-dihydrocortisone-ratio
in urine (p = 0.0119) and the 20β-dihydrocortisol/20β-dihydrocortisone-ratio in urine
(p = 0.0419), respectively. We conclude that the ratios of Cortisol to cortisone and
of the 20-dihydrometabolites of Cortisol to the 20-dihydrometabolites of cortisone
provide a simple noninvasive tool for monitoring the in-vivo activity of the 11β-hydroxysteroid
dehydrogenase.
Key words
Glycyrrhetinic acid - cortisol/cortisone-ratio - 11β-hydroxysteroid dehydrogenase
- apparent mineralocorticoid excess syndrome